D007 Acute Lymphoblastic Leukemia was recognized as a valuable tool for enhanced molecular testing of pediatric acute lympoblastic leukemia (pALL) in a recent research article.
MRC Holland will be closed from December 25, 2025 until January 1, 2026.
We have launched NXtec D024 KaryoProfiler, our newest digitalMLPA™ assay designed for comprehensive molecular karyotyping across a wide range of applications.
Our product packaging will receive updates which simplify processing and pave the way for future innovations – there are no changes to the product contents.
D007 Acute Lymphoblastic Leukemia was recognized as a valuable tool for enhanced molecular testing of pediatric acute lympoblastic leukemia (pALL) in a recent research article.
We have successfully obtained our certification under the new In Vitro Diagnostic Regulation (IVDR; 2017/746)! The first batch of flagship products are already available on the market under the new IVDR, well in advance of the transition period deadline.
Join our mailing list to receive the latest information about our products, technologies and website.